---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-070934"
form_type: "8-K"
ticker: "ALUR"
cik: "0001964979"
company_name: "ALLURION TECHNOLOGIES, INC."
filed_at: "2025-05-14T23:59:59+00:00"
generated_at: "2026-05-21T10:43:55.114749+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Allurion Q1 revenue $5.6M, net operating loss narrows 36% YoY; maintains FY 2025 guide

## Summary
- Q1 revenue of $5.6M (down 40% YoY); gross margin expanded to 75% from 73% YoY.
- Operating expenses fell 37% YoY to $11.4M; adjusted OpEx of $10.1M, down 45%.
- Net operating loss of $7.3M, down 36% YoY; adjusted loss $5.9M, down 48%.
- Cash balance $20.4M; FY 2025 revenue guidance reaffirmed at ~$30M with ~50% OpEx reduction.
- Completed Pre-PMA meeting with FDA; final PMA module submission expected by end of June 2025.

## SEC filing metadata
- accession: 0000950170-25-070934
- form_type: 8-K
- ticker: ALUR
- cik: 0001964979
- company_name: ALLURION TECHNOLOGIES, INC.
- filed_at: 2025-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1964979/000095017025070934/0000950170-25-070934-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964979/000095017025070934/alur-20250514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-070934
- JSON: https://secwatch.observer/filing/0000950170-25-070934.json
- Plain text: https://secwatch.observer/filing/0000950170-25-070934.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.